Fulgent Genetics (FLGT) Acquisitions (2021 - 2026)

Fulgent Genetics (FLGT) posted Acquisitions of $55.6 million for Q1 2026, up 1571.97% sequentially from -$3.8 million in Q3 2025.

Fulgent Genetics (FLGT) Acquisitions (2021 - 2026) Analysis & Trends

Fulgent Genetics has reported Acquisitions for 4 years, with the latest figure at $55.6 million in Q1 2026.

  • Quarterly Acquisitions changed N/A year-over-year to $55.6 million in Q1 2026, while the trailing twelve-month figure through Jun 2026 was $51.8 million (up 48.3% YoY) and the FY2025 annual result came in at -$3.8 million, changed N/A from the prior year.
  • Acquisitions rose to $55.6 million in Q1 2026 per FLGT's latest filing, from -$3.8 million in the prior quarter.
  • Over five years, Acquisitions peaked at $55.6 million in Q1 2026 and troughed at -$3.8 million in Q3 2025.
  • A 3-year average of $28.9 million and a median of $34.9 million in 2022 frame the typical range for Acquisitions.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Thermo Fisher Scientific 213.40 Bn 209.33 Bn 8.34 Bn -
2 Danaher 139.94 Bn 135.59 Bn 3.61 Bn -
3 Idexx Laboratories 46.03 Bn 45.83 Bn 779.09 Mn -
4 Agilent Technologies 39.69 Bn 37.88 Bn 990.00 Mn -
5 Iqvia Holdings 39.32 Bn 37.24 Bn 1.44 Bn 163.00 Mn
6 Natera 38.47 Bn 37.37 Bn 696.04 Mn -
7 Illumina 29.98 Bn 28.82 Bn 770.00 Mn 2.00 Mn
8 Mettler Toledo International 28.57 Bn 28.52 Bn 650.22 Mn -
9 Quest Diagnostics 26.21 Bn 25.58 Bn 1.03 Bn -
10 Fulgent Genetics 515.71 Mn 258.68 Mn 25.68 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 55.57 Mn
Dec 31, 2022 34.92 Mn
Sep 30, 2021 43.36 Mn